BAY 80-6946
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY 80-6946, covering 2017-10-11 to 2017-10-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer [Phase 1]